Stock SNGX SOLIGENIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Soligenix, Inc.

Equities

SNGX

US8342236044

Real-time Estimate Cboe BZX
Other stock markets
 12:25:39 27/06/2024 am IST 		5-day change 1st Jan Change
2.735 USD +3.21% Intraday chart for Soligenix, Inc. -28.26% -78.21%
25/06 Soligenix, Inc. Announces Positive Clinical Results from A Comparative Study Evaluating Hybryte?? Against Valchlor®? in the Treatment of Cutaneous T-Cell Lymphoma CI
23/05 Sector Update: Health Care Stocks Retreat Late Afternoon MT

Evolution of the average Target Price on Soligenix, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1c.4YZiPbkQkw9A2lCos1h7WpNoysZxE1-JeHeI7tjJa_w.kuojS4xK-19w7gb83XUwLfUPi5Y6S2boMSS9ra2IBJ6Z0jZi4GDmORKIFQ~b178221f4092e444e0e6f0d4d7982372

Analyst Recommendations on Soligenix, Inc.

SOLIGENIX : Alliance Global Adjusts Price Target on Soligenix to $3.75 From $5.75, Reiterates Buy Rating MT
SOLIGENIX : B. Riley Lowers Soligenix' PT to $1.50 from $2 on Unchanged Valuation Methodology, Keeps Neutral Rating MT
SOLIGENIX : B. Riley Starts Soligenix at Buy With $4 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.65 USD
Average target price
40 USD
Spread / Average Target
+1,409.43%
High Price Target
48 USD
Spread / Highest target
+1,711.32%
Low Price Target
32 USD
Spread / Lowest Target
+1,107.55%

Consensus detail

Consensus revision (last 18 months)

Ratings for Soligenix, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SNGX Stock
  4. Consensus Soligenix, Inc.